Immucell Corp vs. Idexx Laboratories Inc
Idexx Laboratories Inc (IDXX) comes out ahead, leading on 6 of 9 compared factors.
Size & Scale
| ICCC | IDXX | |
|---|---|---|
| Market Cap | $91.37 million | $43.88 billion |
| Revenue (TTM) | $30.68 million | $4.55 billion |
| Net Income (TTM) | $787,373 | $1.14 billion |
IDXX leads on 3 of 3 size & scale factors.
Valuation
| ICCC | IDXX | |
|---|---|---|
| P/E Ratio | 143.71 | 39.14 |
| Price / Book | 2.91 | 27.21 |
| Price / Sales | 2.98 | 9.64 |
ICCC leads on 2 of 3 valuation factors.
Profitability
| ICCC | IDXX | |
|---|---|---|
| Net Margin | 2.57% | 25.03% |
| Return on Equity | 2.51% | 70.67% |
IDXX leads on 2 of 2 profitability factors.
Risk & Sentiment
| ICCC | IDXX | |
|---|---|---|
| Short Interest | 0.20% | 1.79% |
ICCC leads on 1 of 1 risk & sentiment factors.
Dig deeper: ICCC overview, ICCC financials, IDXX overview, IDXX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.